Tech Company Inital Public Offerings

Entasis Therapeutics IPO

Entasis Therapeutics was acquired by . Shares were listed on 9/25/2018.

Transaction Overview

Announced On
Transaction Type
Proceeds Purpose
Proceeds will be used:to fund the advancement of ETX2514SUL through a Phase 3 clinical trial; to fund the advancement of ETX0282CPDP through a multi-part Phase 1 clinical trial; to fund the selection of an initial clinical candidate from our NBP development program and advance it through a Phase 1 clinical trial; and the remainder to fund other research and development activities, working capital and general corporate purposes.

Company Information

Company Status
Mailing Address
35 Gatehouse Dr.
Waltham, MA 02451
Email Address
Not Recorded
Entasis Therapeutics (Nasdaq: ETTX) is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.
Entasis Therapeutics LinkedIn Company Profile
Social Media
Entasis Therapeutics Company Twitter Account
Company News
Entasis Therapeutics News
Entasis Therapeutics on Facebook
Entasis Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Manos Perros
  Manos Perros LinkedIn Profile  Manos Perros Twitter Account  Manos Perros News  Manos Perros on Facebook
Chief Medical Officer
David Altarac
  David Altarac LinkedIn Profile  David Altarac Twitter Account  David Altarac News  David Altarac on Facebook
Chief Scientific Officer
Ruben Tommasi
  Ruben Tommasi LinkedIn Profile  Ruben Tommasi Twitter Account  Ruben Tommasi News  Ruben Tommasi on Facebook
VP - Bus. Development
Michael Gutch
  Michael Gutch LinkedIn Profile  Michael Gutch Twitter Account  Michael Gutch News  Michael Gutch on Facebook
VP - Bus. Development
Eric Kimble
  Eric Kimble LinkedIn Profile  Eric Kimble Twitter Account  Eric Kimble News  Eric Kimble on Facebook
VP - Bus. Development
John Mueller
  John Mueller LinkedIn Profile  John Mueller Twitter Account  John Mueller News  John Mueller on Facebook



Browse more venture capital transactions:

Prev: 9/25/2018: Renovia venture capital transaction
Next: 9/26/2018: MAXEX venture capital transaction


Share this article


Where The Data Comes From

We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary